Woman and Man
- | Country :
- Russian Federation
- Czech Republic
- Argentina
- The 7 others...
- | organs : -
- | Specialty : -
Extract
The purpose of this study is to evaluate the safety, tolerability, and efficacy of JNJ-40346527 200 mg/day (100 mg twice daily) for 12 weeks, compared with placebo, in patients with active rheumatoid arthritis (RA) despite disease-modifying antirheumatic drug (DMARD) therapy.
Inclusion criteria
- Arthritis (rheumatoid)